# SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury

> **NCT05967325** · NA · UNKNOWN · sponsor: **Kunming Tongren Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Safety Issues

## Interventions

- **PROCEDURE:** Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels

## Key facts

- **NCT ID:** NCT05967325
- **Lead sponsor:** Kunming Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-15
- **Primary completion:** 2024-07-15
- **Final completion:** 2025-07-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05967325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05967325, "SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05967325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*